Abstract
Multi-morphologic polymer nano-assemblies, such as micelles and vesicles, have been intensively studied recently by scientists in the multidisciplinary fields for their promising applications in bioengineering, biomedicine and pharmaceutics. With the success of several micellar formulations in clinical trials, more and more therapeutics based on polymer assemblies are on the pipeline for clinical applications. The current review summarizes some recent patents on the polymer nano-assemblies including micelles and vesicles, with the focus on drug delivery and gene therapy. For the lack of updated patents, the selected progress made most recently in this field has been presented based on the newly published articles. The future development in this active and exciting field has been discussed as well. Because of the huge literature of scientific papers on delivery systems based on polymer assemblies in recent years, this review attempts to limit the specific examples to those that are currently in clinical trials. Accordingly, it is impossible to properly credit all the scientists in this field. The author apologizes in advance for all omissions.
Keywords: Self-assembly, polymeric assemblies, micelles, vesicles, polymersomes, drug delivery, gene delivery, nanomedicine
Recent Patents on Nanotechnology
Title: Polymeric Nano-Assemblies as Emerging Delivery Carriers for Therapeutic Applications: A Review of Recent Patents
Volume: 3 Issue: 3
Author(s): Jianxiang Zhang, Shuhui Li and Xiaohui Li
Affiliation:
Keywords: Self-assembly, polymeric assemblies, micelles, vesicles, polymersomes, drug delivery, gene delivery, nanomedicine
Abstract: Multi-morphologic polymer nano-assemblies, such as micelles and vesicles, have been intensively studied recently by scientists in the multidisciplinary fields for their promising applications in bioengineering, biomedicine and pharmaceutics. With the success of several micellar formulations in clinical trials, more and more therapeutics based on polymer assemblies are on the pipeline for clinical applications. The current review summarizes some recent patents on the polymer nano-assemblies including micelles and vesicles, with the focus on drug delivery and gene therapy. For the lack of updated patents, the selected progress made most recently in this field has been presented based on the newly published articles. The future development in this active and exciting field has been discussed as well. Because of the huge literature of scientific papers on delivery systems based on polymer assemblies in recent years, this review attempts to limit the specific examples to those that are currently in clinical trials. Accordingly, it is impossible to properly credit all the scientists in this field. The author apologizes in advance for all omissions.
Export Options
About this article
Cite this article as:
Zhang Jianxiang, Li Shuhui and Li Xiaohui, Polymeric Nano-Assemblies as Emerging Delivery Carriers for Therapeutic Applications: A Review of Recent Patents, Recent Patents on Nanotechnology 2009; 3 (3) . https://dx.doi.org/10.2174/187221009789177803
DOI https://dx.doi.org/10.2174/187221009789177803 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
Call for Papers in Thematic Issues
Advances in Vanadium and Titanium Resources for High-performance Materials via Nanostructuring and Nanoengineering (updated BMS-NANOTEC-2023-HT-31)
Vanadium and titanium-based materials are ideal candidates for structural and functional materials in aerospace, biomedical engineering, optics, catalysis, energy storage and conversion etc. Vanadium/titanium-based alloys, compounds and materials have a large family with different chemical compositions, dimensions, structures/morphologies, and chemical/physical/mechanical properties, which provides huge opportunities for the development of emerging ...read more
Green Nanotechnology and Nanomaterials for a Sustainable Environment
Green nanotechnology (GN) might wind up being the most efficient platform for achieving the goals of the 2030 Agenda. The goal of GN is to create goods and procedures that are secure, energy-efficient, waste-free, and emit fewer greenhouse gases. Such goods and procedures use renewable resources, and/or their environmental impact ...read more
Nano-coatings and Nanoscale Composites for Hazardous Environments
Automobile, defence, and aerospace sectors need lightweight material for fuel efficiency and lower emissions. Often these materials are added with nanoscale reinforcements or have to be coated with nanomaterials to improve the scratch resistance, self-healing behaviour and corrosion and wear resistance and are all much needed for hazardous environments without ...read more
NANOSTRUCTURED NEUROMORPHIC DEVICES: TOWARDS IN MATERIA COMPUTING
The efforts pursued in the last decade to build up brain-inspired systems with electronic hardware solutions to solve complex data processing tasks, have leaded to the development of a new generation of devices, as memristor crossbar arrays, and their different applications became more and more reliable. One of the basic ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches
Current Medical Imaging Advances in Efficient Health Communication: Promoting Prevention and Detection of STDs
Current HIV Research Experimental Targeted Therapy Using [211At]meta-Astatobenzylguanidine and Transfection of the Noradrenaline Transporter Gene
Current Radiopharmaceuticals Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Editorial from Guest Editor [Hot Topic: Familial and Hereditary Breast and Ovarian Tumors (Guest Editors: Antonio Russo and Massimo Federico)]
Current Women`s Health Reviews The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery <i>In Vitro</i> Protective Potentials of <i>Annona muricata</i> Leaf Extracts Against Sodium Arsenite-induced Toxicity
Current Drug Discovery Technologies To Seek Shelter from the Wnt in Osteoarthritis? Wnt-Signaling as a Target for Osteoarthritis Therapy
Current Drug Targets Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Current Medicinal Chemistry P2X Receptors and Inflammation
Current Medicinal Chemistry Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance
Current Medicinal Chemistry Meet Our Associate Editorial Board Member
Current Nanomedicine <i>In Vivo</i> Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice
Anti-Cancer Agents in Medicinal Chemistry Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline
Current Nanoscience Inhibition of Rho/Rho-Kinase as Therapeutic Strategy to Promote CNS Axonal Regeneration
Central Nervous System Agents in Medicinal Chemistry Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology Furanocoumarin A: A Novel Anticancer Agent on Human Lung Cancer A549 Cells from Fructus liquidambaris
Anti-Cancer Agents in Medicinal Chemistry Subject Index To Volume 8
Current Pharmaceutical Design